e 64 has been researched along with chlorhexidine in 3 studies
| Studies (e 64) | Trials (e 64) | Recent Studies (post-2010) (e 64) | Studies (chlorhexidine) | Trials (chlorhexidine) | Recent Studies (post-2010) (chlorhexidine) |
|---|---|---|---|---|---|
| 477 | 1 | 103 | 9,521 | 2,099 | 3,952 |
| Protein | Taxonomy | e 64 (IC50) | chlorhexidine (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 4.0045 | |
| perilipin-1 | Homo sapiens (human) | 2.2083 | |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 2.6045 | |
| melanocortin receptor 4 | Homo sapiens (human) | 1.997 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 3.5425 | |
| hexokinase HKDC1 | Homo sapiens (human) | 8.99 | |
| Synaptojanin-2 | Homo sapiens (human) | 10 | |
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.4 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 0.21 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.41 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 7.63 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 7.63 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 0.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barros, N; Breschi, L; Carmona, AK; Carrilho, MR; Gesteira, TF; Nascimento, FD; Pashley, DH; Scaffa, PM; Tersariol, IL; Tjäderhane, L; Vidal, CM | 1 |
3 other study(ies) available for e 64 and chlorhexidine
| Article | Year |
|---|---|
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chlorhexidine inhibits the activity of dental cysteine cathepsins.
Topics: Adult; Cathepsin B; Cathepsin K; Cathepsin L; Cathepsins; Chlorhexidine; Coumarins; Cysteine Proteinase Inhibitors; Dentin; Dipeptides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; Humans; Hydrolysis; Leucine; Matrix Metalloproteinase Inhibitors; Models, Molecular; Protein Binding; Protein Conformation; Recombinant Proteins; Spectrometry, Fluorescence; Young Adult | 2012 |